Biogen BIIB and Amgen AMGN are two of the biggest biotech companies in the world. Amgen has a strong presence in the oncology, general medicine, inflammation and rare diseases markets. Biogen is ...

Amgen is scrapping an experimental weight loss pill but moving forward with an injection. Amgen will release initial data from a mid-stage study on its injectable drug later this year, and the company ...

Amgen AMGN delivered yet another strong quarterly performance. Its second-quarter 2025 earnings and sales beat estimates. The company has been recording consistently strong top-line performance. Amgen ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

During the Q&A portion of Amgen’s quarterly conference call Thursday, eight of the first nine questions were about the company’s investigational efforts in obesity. The buzz about Amgen’s pipeline—and ...

Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run direct-to-consumer platform for pharmaceutical products continues to expand, Fox ...

Amgen lost patent protection for Prolia, a medicine for bone health, earlier this year. In the next few years, it will encounter other patent cliffs, including that of the cancer drug Krypolis and the ...

Amgen on Thursday said it will stop developing its experimental weight loss pill and instead move forward with its injectable drug and other products in development for obesity. Amgen is among several ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The European Medicines Agency's Committee for Medicinal Products for Human Use ...